iBio, Inc.
IBIO
$4.59
-$0.27-5.56%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.36M | -3.99M | -7.78M | -3.17M | -8.21M |
| Total Depreciation and Amortization | 281.00K | 278.00K | 289.00K | 329.00K | 316.00K |
| Total Amortization of Deferred Charges | -- | -- | 0.00 | 0.00 | 30.00K |
| Total Other Non-Cash Items | 461.00K | 396.00K | 4.88M | -706.00K | 3.28M |
| Change in Net Operating Assets | -247.00K | -400.00K | -2.25M | -105.00K | -120.00K |
| Cash from Operations | -3.87M | -3.72M | -4.85M | -3.65M | -4.71M |
| Capital Expenditure | -1.00K | -- | -210.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 66.00K | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | 713.00K | 0.00 | 1.00M | -- |
| Cash from Investing | -2.00K | 713.00K | -144.00K | 1.00M | 0.00 |
| Total Debt Issued | -- | -- | 0.00 | 895.00K | -- |
| Total Debt Repaid | -170.00K | -166.00K | -1.24M | -147.00K | -107.00K |
| Issuance of Common Stock | 18.00K | 4.00K | 14.23M | 4.28M | 4.12M |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -7.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.00K | 1.00K | -- |
| Cash from Financing | -152.00K | -162.00K | 12.99M | 5.03M | 4.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.02M | -3.16M | 7.99M | 2.37M | -701.00K |
